Patents Assigned to Bristol-Myers Squibb, Inc.
  • Antibodies Binding to VISTA at Acidic pH
    Publication number: 20240092907
    Abstract: The present application relates to antibodies specifically binding to the V-domain immunoglobulin-containing suppressor of T-cell activation (VISTA) at acidic pH and their use in cancer treatment. In some embodiments, the antibodies bind specifically to human VISTA at acidic pH, but do not significantly bind to human VISTA at neutral or physiological pH.
    Type: Application
    Filed: February 1, 2023
    Publication date: March 21, 2024
    Applicants: Five Prime Therapeutics, Inc., Bristol-Myers Squibb Company
    Inventors: Robert J. Johnston, Arvind Rajpal, Paul O. Sheppard, Luis Borges, Andrew Rankin, Keith Sadoon Bahjat, Alan J. Korman, Andy X. Deng, Lin Hui Su, Ginger Rakestraw
  • Methods for modulating tumor growth and metastasis
    Patent number: 7037906
    Abstract: Methods and pharmaceutical compositions for modulating tumor growth or metastasis are provided.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: May 2, 2006
    Assignees: Oxigene, Inc., Bristol-Myers Squibb, Inc.
    Inventor: Francis Y. Lee